Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10299287 | European Neuropsychopharmacology | 2014 | 142 Pages |
Abstract
While mental health and mental disorders have significant representation in the “health, demographic change and wellbeing” challenge identified in Horizon 2020, the framework programme for research and innovation of the European Commission (2014-2020), and in national funding agencies, clear advice on a potential strategy for mental health research investment is needed. The development of such a strategy is supported by the EC-funded “Roadmap for Mental Health Research” (ROAMER) which will provide recommendations for a European mental health research strategy integrating the areas of biomedicine, psychology, public health well being, research integration and structuring, and stakeholder participation. Leading experts on biomedical research on mental disorders have provided an assessment of the state of the art in core psychopathological domains, including arousal and stress regulation, affect, cognition social processes, comorbidity and pharmacotherapy. They have identified major advances and promising methods and pointed out gaps to be addressed in order to achieve the promise of a stratified medicine for mental disorders.
Related Topics
Life Sciences
Neuroscience
Biological Psychiatry
Authors
Gunter Schumann, Elisabeth B. Binder, Arne Holte, E. Ronald de Kloet, Ketil J. Oedegaard, Trevor W. Robbins, Tom R. Walker-Tilley, Istvan Bitter, Verity J. Brown, Jan Buitelaar, Roberto Ciccocioppo, Roshan Cools, Carles Escera, Wolfgang Fleischhacker,